PSMA positive LNCaP cells were more sensitive to APT-CUR/CTX-LPNs than PSMA negative PC3 cells, which suggests that APT-CUR/CTX-LPNs have the capacity to target PSMA positive cancer cells (249). Here, FOLH1 is linked to cancer.